5-Acetamido-1,3,4-thiadiazole-2-sulfonyl chloride

Catalog No. :
ACNCEO714
CAS No. :
32873-57-7
Molecular Formula :
C4H4ClN3O3S2
Molecular Weight :
241.68

IUPAC Name:5-acetamido-1,3,4-thiadiazole-2-sulfonyl chloride

5-Acetamido-1,3,4-thiadiazole-2-sulfonyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$504.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Acetamido-1,3,4-thiadiazole-2-sulfonyl chloride
IUPAC Name5-acetamido-1,3,4-thiadiazole-2-sulfonyl chloride
MDL No.MFCD00702860
Molecular FormulaC4H4ClN3O3S2
Molecular Weight241.68
SMILESO=S(C1=NN=C(NC(C)=O)S1)(Cl)=O
InChI KeyMEJAPGGFIJZHEJ-UHFFFAOYSA-N
Synonym2-(ACETAMIDO)-5-(CHLOROSULFONYL)-1,3,4-THIADIAZOLE;2-(Acetamido)-5-(chlorosulfonyl)-1,3,4-thiadiazole 5-(Acetylamino)-1,3,4-thiadiazole-2-sulfonyl chloride;5-(acetylamino)-1,3,4-Thiadiazole-2-sulfonyl chloride;5-acetamido-1,3,4-thiadiazole-2-sulfonyl chloride;5-acetamido-1,3,4-thiadiazolyl-2-sulfonyl chloride;1,3,4-Thiadiazole-2-sulfonyl chloride, 5-(acetylamino)-;Acetazolamide Impurity 8;Acetazolamide Impurity 5
CAS No.32873-57-7

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACNCEO714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPIUT251 route compound structure diagram
    ACPIUT25132873-56-6 In Stock
  2. Then
  3. ACNCEO714 route product structure diagram
    ACNCEO71432873-57-7
Inquiry

2. ACNCEO714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNCEO714 route product structure diagram
    ACNCEO71432873-57-7
Inquiry

Comments (0)